Does <i>de novo</i> malignancy heighten the risk of rejection in kidney transplant recipients?

Although overall mortality rates were higher in the malignancy group compared with the control group, this difference did not reach statistical significance ( P = .25) ( Supplementary data, Fig.

also in 111,027 other papers